AAAAAA

   
Results: 1-15 |
Results: 15
SIGNIFICANCE OF CYTOMEGALOVIRUS FOR LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER-TRANSPLANTATION - A PROSPECTIVE DERIVATION AND VALIDATION COHORT ANALYSIS
Authors: FALAGAS ME PAYA C RUTHAZER R BADLEY A PATEL R WIESNER R GRIFFITH J FREEMAN R ROHRER R WERNER BG SNYDMAN DR
Citation: Me. Falagas et al., SIGNIFICANCE OF CYTOMEGALOVIRUS FOR LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER-TRANSPLANTATION - A PROSPECTIVE DERIVATION AND VALIDATION COHORT ANALYSIS, Transplantation, 66(8), 1998, pp. 1020-1028
CLINICAL AND EPIDEMIOLOGIC PREDICTORS OF RECURRENT CYTOMEGALOVIRUS DISEASE IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SNYDMAN DR GRIFFITH J WERNER BG FREEMAN R ROHRER R FAIRCHILD R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., CLINICAL AND EPIDEMIOLOGIC PREDICTORS OF RECURRENT CYTOMEGALOVIRUS DISEASE IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 25(2), 1997, pp. 314-317
SURVEILLANCE CULTURES OF BLOOD, URINE, AND THROAT SPECIMENS ARE NOT VALUABLE FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SNYDMAN DR RUTHAZER R WERNER BG GRIFFITH J ROHRER R FREEMAN R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M FAIRCHILD R WERNER BG GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., SURVEILLANCE CULTURES OF BLOOD, URINE, AND THROAT SPECIMENS ARE NOT VALUABLE FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 24(5), 1997, pp. 824-829
CYTOMEGALOVIRUS IMMUNE GLOBULIN (CMVIG) PROPHYLAXIS IS ASSOCIATED WITH INCREASED SURVIVAL AFTER ORTHOTOPIC LIVER-TRANSPLANTATION
Authors: FALAGAS ME SNYDMAN DR RUTHAZER R GRIFFITH J WERNER BG FREEMAN R ROHRER R
Citation: Me. Falagas et al., CYTOMEGALOVIRUS IMMUNE GLOBULIN (CMVIG) PROPHYLAXIS IS ASSOCIATED WITH INCREASED SURVIVAL AFTER ORTHOTOPIC LIVER-TRANSPLANTATION, Clinical transplantation, 11(5), 1997, pp. 432-437
CYTOMEGALOVIRUS DISEASE IS ASSOCIATED WITH INCREASED COST AND HOSPITAL LENGTH OF STAY AMONG ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME ARBO M RUTHAZER R GRIFFITH JL WERNER BG ROHRER R FREEMAN R LEWIS WD SNYDMAN DR
Citation: Me. Falagas et al., CYTOMEGALOVIRUS DISEASE IS ASSOCIATED WITH INCREASED COST AND HOSPITAL LENGTH OF STAY AMONG ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Transplantation, 63(11), 1997, pp. 1595-1601
EFFECT OF CYTOMEGALOVIRUS-INFECTION STATUS ON FIRST-YEAR MORTALITY-RATES AMONG ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SYNDMAN DR GRIFFITH J RUTHAZER R WERNER BG ROHRER R FREEMAN R FAIRCHILD R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., EFFECT OF CYTOMEGALOVIRUS-INFECTION STATUS ON FIRST-YEAR MORTALITY-RATES AMONG ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Annals of internal medicine, 126(4), 1997, pp. 275
THE INDEPENDENT ROLE OF CYTOMEGALOVIRUS AS A RISK FACTOR FOR INVASIVEFUNGAL DISEASE IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: GEORGE MJ SNYDMAN DR WERNER BG GRIFFITH J FALAGAS ME DOUGHERTY NN RUBIN RH
Citation: Mj. George et al., THE INDEPENDENT ROLE OF CYTOMEGALOVIRUS AS A RISK FACTOR FOR INVASIVEFUNGAL DISEASE IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, The American journal of medicine, 103(2), 1997, pp. 106-113
EXPOSURE TO CYTOMEGALOVIRUS FROM THE DONATED ORGAN IS A RISK FACTOR FOR BACTEREMIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SNYDMAN DR GRIFFITH J WERNER BG ROHRER R FREEMAN R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M FAIRCHILD R GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., EXPOSURE TO CYTOMEGALOVIRUS FROM THE DONATED ORGAN IS A RISK FACTOR FOR BACTEREMIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 23(3), 1996, pp. 468-474
PRIMARY CYTOMEGALOVIRUS-INFECTION IN LIVER-TRANSPLANT RECIPIENTS - COMPARISON OF INFECTIONS TRANSMITTED VIA DONOR ORGANS AND VIA TRANSFUSIONS
Authors: FALAGAS ME SNYDMAN DR RUTHAZER R GRIFFITH J WERNER BG ROHRER R FREEMAN R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS D HAMMER S MARTIN M FAIRCHILD R GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., PRIMARY CYTOMEGALOVIRUS-INFECTION IN LIVER-TRANSPLANT RECIPIENTS - COMPARISON OF INFECTIONS TRANSMITTED VIA DONOR ORGANS AND VIA TRANSFUSIONS, Clinical infectious diseases, 23(2), 1996, pp. 292-297
INCIDENCE AND PREDICTORS OF CYTOMEGALOVIRUS PNEUMONIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SNYDMAN DR GEORGE MJ WERNER B RUTHAZER R GRIFFITH J ROHRER RH FREEMAN R GEORGE MG FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORNA M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M FAIRCHILD R WERNER BG GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., INCIDENCE AND PREDICTORS OF CYTOMEGALOVIRUS PNEUMONIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Transplantation, 61(12), 1996, pp. 1716-1720
USE OF CYTOMEGALOVIRUS IMMUNOGLOBULIN IN MULTIPLY TRANSFUSED PREMATURE NEONATES
Authors: SNYDMAN DR WERNER BG MEISSNER HC CHEESEMAN SH SCHWAB J BEDNAREK F KENNEDY JL HERSCHEL M MAGNO A LEVIN MJ VALAES T BERKMAN E MCIVER J LESZCZYNSKI J GRIFFITH J GRADY GF
Citation: Dr. Snydman et al., USE OF CYTOMEGALOVIRUS IMMUNOGLOBULIN IN MULTIPLY TRANSFUSED PREMATURE NEONATES, The Pediatric infectious disease journal, 14(1), 1995, pp. 34-40
SCREENING AND CONFIRMATORY TESTING OF CADAVER ORGAN DONORS FOR HEPATITIS-C VIRUS-INFECTION - A US NATIONAL COLLABORATIVE STUDY
Authors: PEREIRA BJG WRIGHT TL SCHMID CH BRYAN CF CHEUNG RC COOPER ES HSU H HEYNLAMB R LIGHT JA NORMAN DJ VANTHIEL DH WERNER BG WRIGHT CE LEVEY AS
Citation: Bjg. Pereira et al., SCREENING AND CONFIRMATORY TESTING OF CADAVER ORGAN DONORS FOR HEPATITIS-C VIRUS-INFECTION - A US NATIONAL COLLABORATIVE STUDY, Kidney international, 46(3), 1994, pp. 886-892
A FURTHER ANALYSIS OF THE USE OF CYTOMEGALOVIRUS IMMUNE GLOBULIN IN ORTHOTOPIC LIVER-TRANSPLANT PATIENTS AT RISK FOR PRIMARY INFECTION
Authors: SNYDMAN DR WERNER BG DOUGHERTY NN GRIFFITH J ROHRER RH FREEMAN R JENKINS R LEWIS WD OROURKE E FAWAZ K HOFFMAN MA KAPLAN M BAREFOOT L RUBIN RH DIENSTAG JL DORAN M VACANTI J HAMMER S MARTIN M FAIRCHILD R GRADY GF LESZCZYNSKI J KATZ A FAUSETT G
Citation: Dr. Snydman et al., A FURTHER ANALYSIS OF THE USE OF CYTOMEGALOVIRUS IMMUNE GLOBULIN IN ORTHOTOPIC LIVER-TRANSPLANT PATIENTS AT RISK FOR PRIMARY INFECTION, Transplantation proceedings, 26(5), 1994, pp. 23-27
USE OF GANCICLOVIR PLUS CYTOMEGALOVIRUS IMMUNE GLOBULIN TO TREAT CMV PNEUMONIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: GEORGE MJ SNYDMAN DR WERNER BG DOUGHERTY NN GRIFFITH J ROHRER RH FREEMAN R JENKINS R LEWIS WD
Citation: Mj. George et al., USE OF GANCICLOVIR PLUS CYTOMEGALOVIRUS IMMUNE GLOBULIN TO TREAT CMV PNEUMONIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Transplantation proceedings, 25(5), 1993, pp. 22-24
CYTOMEGALOVIRUS IMMUNE GLOBULIN PROPHYLAXIS IN LIVER-TRANSPLANTATION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: SNYDMAN DR WERNER BG DOUGHERTY NN GRIFFITH J RUBIN RH DIENSTAG JL ROHRER RH FREEMAN R JENKINS R LEWIS D HAMMER S OROURKE E GRADY GF FAWAZ K KAPLAN MM HOFFMAN MA KATZ AT DORAN M
Citation: Dr. Snydman et al., CYTOMEGALOVIRUS IMMUNE GLOBULIN PROPHYLAXIS IN LIVER-TRANSPLANTATION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 119(10), 1993, pp. 984-991
Risultati: 1-15 |